#fda-warning

#fda-warning

Counterfeit Ozempic identified in US supply, prompting FDA warning to healthcare providers and consumers.

FDA warns of counterfeit Ozempic affecting patient safety.

Report includes details about counterfeit serial numbers.

Novo Nordisk acknowledges multiple counterfeit incidents.

Significant bacteria violations found at Tom's of Maine manufacturing facility could pose health risks, especially for immunocompromised individuals, prompting consumer concerns.

Smartphone app notifications for diabetes management are crucial; missing them can lead to health emergencies.

Consumers falling ill after eating Diamond Shruumz's 'microdosing' chocolate bars, lacking psychedelic mushrooms.

The FDA has warned against contaminated oysters from British Columbia linked to norovirus, urging disposal or return of affected products.

FDA warns of liver damage risk associated with menopause drug Veozah, advising patients on monitoring and symptoms.

Consumers urged to avoid shellfish from contaminated areas to prevent paralytic shellfish poisoning.

Federal officials issued warnings to companies for illegally selling food products mimicking popular brands with delta-8 THC, posing health risks due to potential impurities and confusion.

Tom's of Maine toothpaste contained harmful bacteria, prompting an FDA warning and highlighting potential risks to consumer health.

Dosing errors with compounded weight-loss products resulted in overdoses, leading to severe symptoms and hospitalization.

People are excited about weight loss potential of semaglutide but need caution on proper dosing to avoid adverse effects.